Essentials - Management of Withdrawal - Opioids, Alcohol and Benzodiazepines
Essentials - Medical Complications of SUDs
Essentials - Cannabis use disorder: Prevalence and Consequences
The 8-hour Buprenorphine Training - PART 1
The 8-hour Buprenorphine Training - PART 1
The 8-hour Buprenorphine Training - PART 1
The 8-hour Buprenorphine Training - PART 1 - 1/14/2023
The 8-hour Buprenorphine Training - PART 1
The 8-hour Buprenorphine Training - PART 1 - 2/11/2023
The 8-hour Buprenorphine Training - PART 1 - 3/11/2023
The 8-hour Buprenorphine Training - PART 1 - 2/27/2023
The 8-hour Buprenorphine Training - PART 1 - 3/27/2023
The 8-hour Buprenorphine Training - PART 1 - 4/8/2023
STUDENT OSTEOPATHIC MEDICAL ASSOCIATION COURSE (SOMA) - The 8-hour Buprenorphine Training PART 1 - 03/04/2023
ORN Spring 2023 - Innovation and Regulation: Improving Methadone Access While Maintaining Treatment Quality and Safety
ORN Spring 2023 - Medicaid Managed Care Coverage for Substance Use Disorder Treatment
ORN Spring 2023 - Why Preventing Drug Overdose Deaths is a Moving Target: Dynamic Shifts to the Opioid Crisis by Age, Race, Supply, Demand, and Geography
ORN Spring 2023 - Reducing Health Harms for People who Inject Drugs in Appalachia - Research and Practice Partnerships in Syringe Service Programs
ORN Spring 2023 - Isn't There a Better Way? Mitigating the Harms of Criminal Legal Involvement for Pregnant People Who Use Drugs
Addressing SUD/MAT in the Emergency Department Setting
Opioid Treatment Programs
Veterans and Active-Duty Military Issues in SUD
Criminal Justice Settings: Buprenorphine & Fentanyl in E.R. and Adult Drug Treatment Courts, Jail and Prison
DEA- Addiction Medicine Essentials Course- AOA/AOAAM
ORN Fall 2023 - Opioid Use Disorder, Depression & Suicide: Overlapping Risk & Treatment Challenges
ORN Fall 2023 - New Approaches to Methamphetamine Addiction and Psychosis
ORN Fall 2023 - Operationalizing a Definition of Precipitated Withdrawal and the Absorption, Distribution, Metabolism, and Elimination of Illicitly Manufactured Fentanyl
ORN Fall 2023 - Xylazine - An Introduction to a New Drug
ORN Fall 2023 - Brixadi (buprenorphine-XR) for the Treatment of Opioid Use Disorder
ORN Fall 2023 - The Evolution of Buprenorphine: Prescribing practices and efforts to increase MOUD access
ORN Fall 2023 - Update on the U.S. Overdose Crisis: Which drugs, who is dying, and how do we save lives?
ORN Fall 2022 #1 - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
ORN Fall 2022 #2 - Case Studies and Q/A - Trials and Tribulations of ED Initiation of Buprenorphine in the Age of Fentanyl
ORN Fall 2022 #3 - Managing Opioid Complexity in Individuals with Serious Illness
ORN Fall 2022 #4 - Case Studies and Q/A - Managing Opioid Complexity in Individuals with Serious Illness
ORN Fall 2022 #5 - The State of Harm Reduction in the US: Progress, Barriers, and What's Next
ORN Fall 2022 #6 - Case Studies and Q/A - The State of Harm Reduction in the US: Progress, Barriers, and What's Next
ORN Spring 2022 #1 - The impact of illicit fentanyl use on opioid use disorder treatment
ORN Spring 2022 #2 - Case Studies and QandA: The impact of illicit fentanyl use on opioid use disorder treatment
ORN Spring 2022 #3 - Drugs, Stigma, and Health
ORN Spring 2022 #4 - Case Studies and QandA: Drugs, Stigma, and Health
ORN Spring 2022 #5 - The Fourth Wave: Addressing the Intertwined Fentanyl and Stimulant Overdose Crisis
ORN Spring 2022 #6 - Case Studies and QandA: The Fourth Wave: Addressing the Intertwined Fentanyl and Stimulant Overdose Crisis
Public Health Implications of Expanded Marijuana Programs
BAD MEDICINE: Mental Health and What the Opioid Epidemic Can Teach Us About Cannabis
Student Osteopathic Medical Association (SOMA) - The 8-hour MOUD Training - PART 1 - 11/18/2023 (counts towards the DEA’s 8-hour training requirement)
Cannabis and Adolescent Brain Development
Negative Impacts of High Potency THC on the Developing Brain and Mental Health - This Is NOT "Medicine"
ORN Spring 2024 - Maternal Morbidity and Mortality Associated with Methamphetamine and Other Substance Use in the Perinatal Period
ORN Spring 2024 - Opioid Use Disorder in Youth
ORN Spring 2024 - Psychostimulant Toxicity
ORN Spring 2024 - Exploring the Interface of Cannabis, Cannabinoids, and Opioid Use Disorder: Clinical Insights and Emerging Research
ORN Spring 2024 - ED Treatment of Opioid Use Disorder: Truth, Trends and Treatments
ORN Spring 2024 - Opioid Prescribing by Dentists and Oral Maxillofacial Surgeons
Cognitive Behavior Therapy Skills for Healthcare Providers
Mutual Help Groups for Addiction
Motivational Interviewing - Practices from the Heart
Contingency Management for the Treatment of Substance Use Disorders
The 8-hour MOUD Training - PART 1 - 5/18/2024
The 8-hour MOUD Training - PART 1 - 7/22/2024
ORN Summer 2024 - Xylazine Wound Care Clinic and Protocol
ORN Summer 2024 - Clinical Implications of the Relationship Between Naltrexone Plasma Levels and the Subjective Effects of Heroin in Humans
ORN Summer 2024 - Extended-Release Buprenorphine
ORN Summer 2024 - Kratom Consumers in the United States: What clinicians need to know
ORN Summer 2024 - Hepatitis C Virus in Pregnancy: An Opportunity to Screen and Treat
ORN Summer 2024 - Drugs & Bugs: Case-Based Pearls for Integrated SUD-Infectious Diseases Care in the Hospital
Situating Harm Reduction Along the Continuum of Care for People with Substance Use Disorder
AOAAM Addiction Medicine Board Certification Review Course
Essentials - Acute Post-Operative Pregnancy Pain with At-Risk Women
Essentials - Adolescent Substance Use- How to Recognize Screen and Communicate
Essentials - Assessment and Management of Tobacco Use Disorders
Essentials - Assessment of Patients with Substance Use Disorders
Essentials - Co-occurring and Substance Induced Disorders
Essentials - Motivational Interviewing
Essentials - Sleep Problems Complicated by Substance Use Disorders
Essentials: 12 Step Program
Essentials: Addiction Medicine: The Elephant in the Middle of Healthcare
Essentials: Alcohol Use Problems: Recommendations for Medical Management
Essentials: General Principles of Drug Testing
Essentials: Neurobiology of Addictions
Essentials: Opioid Use Problems: Recommendations for Medical Management
Essentials: Pain and Addiction
Essentials: Prescribing Naloxone to Patients for Overdose Reversal
Essentials: Psychosocial Treatments for Substance Use Disorder
Essentials: Stimulant Use Disorder
2024 JAD Article 1 - Peer Review
2024 JAD Article 2 - Peer Review
2024 JAD Article 3 - Peer Review
2024 JAD Article 4 - Peer Review
2024 JAD Article 5 - Peer Review
2024 JAD Article 6 - Peer Review
2024 JAD Article 7 - Peer Review
2024 JAD Article 8 - Peer Review
2024 JAD Article 9 - Peer Review
2024 JAD Article 10 - Peer Review
ORN Webinar Fall 2021 #1 - Benzodiazepines and Opioid Maintenance Treatment: The Risks and the Benefits
ORN Webinar Fall 2021 #2 - Case Studies and Q&A: Benzodiazepines and Opioid Maintenance Treatment
ORN Webinar Fall 2021 #3 - COVID 19 Changes to Methadone Treatment at One Clinic in Central Pennsylvania
ORN Webinar Fall 2021 #4 - Case Studies and Q&A: COVID 19 Changes to Methadone Treatment at One Clinic in Central Pennsylvania
ORN Webinar Fall 2021 #5 - Treating Opioid Use Disorder in Pregnancy and the Perinatal Period
ORN Webinar Fall 2021 #6 - Case Studies and Q&A: Treating Opioid Use Disorder in Pregnancy and the Perinatal Period
Testimonies from the Trenches Series - Buprenorphine in Residential Treatment Settings (On-Demand)
Testimonies from the Trenches Series - Low-Barrier Buprenorphine Treatment (On-Demand)
Testimonies from the Trenches Series - Reconsidering the Role of Urine Drug Testing in OUD Treatment (On-Demand)
Testimonies from the Trenches Series - Safer Pain Management Practices for Patients with Opioid Use Disorder (On-Demand)
Disclaimer
Credit Statement
Credit Statement - AOA Category 1-A
AVAILABLE ON-DEMAND
Claim Credits & Course Materials
Funding
What is ORN?